AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20681233 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic nocturnal sleep restriction (4 h/d for 8 days)
Number of subjects: 90
Study 20681233 — intervention group
Group type: COMPARATOR
Intervention: Time of day (0800 vs 1800)
Number of subjects: 90
Study 20681233 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal nap (part of the 18 schedules)
Number of subjects: 90
Study 18027038 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg i.v.
Number of subjects: 80
Study 18027038 — intervention group
Group type: EXPERIMENTAL
Intervention: granisetron 3 mg i.v.
Number of subjects: 80
Study 18027038 — intervention group
Group type: EXPERIMENTAL
Intervention: dexamethasone 8 mg i.v.
Number of subjects: 80
Study 18027038 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (placebo)
Number of subjects: 80
Study 16822135 — intervention group
Group type: EXPERIMENTAL
Intervention: Resonance frequency as the stimulus dimension
Number of subjects: 0
Study 16822135 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration as the stimulus dimension
Number of subjects: 0
Study 16822135 — intervention group
Group type: EXPERIMENTAL
Intervention: New categorization model combining aspects of decision-bound and distribution theories
Number of subjects: 0
Study 12819249 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 124
Study 10792122 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral magnesium sulphate (MgSO4)
Number of subjects: 8
Study 10792122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9094893 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg Fe once weekly
Number of subjects: 289
Study 9094893 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg Fe once weekly with anthelminthic treatment
Number of subjects: 289
Study 9094893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 8194433 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10‐40mg/day (mean 17.9mg/day)
Number of subjects: 59
Study 8194433 — intervention group
Group type: COMPARATOR
Intervention: Gemfibrozil 1200mg/day
Number of subjects: 59
Study 3465753 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-headed toothbrush
Number of subjects: 34
Study 3465753 — intervention group
Group type: COMPARATOR
Intervention: Single-headed toothbrush
Number of subjects: 34
Study 3465753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothbrushes
Number of subjects: 34
Study 28919067 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepcidin quantification and treatment based on hepcidin levels
Number of subjects: 0
Study 28919067 — intervention group
Group type: COMPARATOR
Intervention: Conventional ferritin methods for diagnosing ID
Number of subjects: 0
Study 28919067 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepcidin treatment recommendations: IV iron when hepcidin <20μg/L; IV iron + erythropoietin when hepcidin 20-41μg/L
Number of subjects: 0
Study 25755063 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-BMCs (hypoxia-preconditioned bone marrow mononuclear cells)
Number of subjects: 36
Study 25755063 — intervention group
Group type: EXPERIMENTAL
Intervention: N-BMCs (normoxia bone marrow mononuclear cells)
Number of subjects: 36
Study 25755063 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 36
Study 25755063 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-BMCs
Number of subjects: 36
Study 25755063 — intervention group
Group type: EXPERIMENTAL
Intervention: N-BMCs
Number of subjects: 36
Study 23943134 — intervention group
Group type: EXPERIMENTAL
Intervention: Book‐supported primary prevention program 'Dominique's Handy Tricks'
Number of subjects: 46
Study 21727253 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 117
Study 21727253 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 117
Study 21727253 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 117
Study 19827103 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy (empowerment group)
Number of subjects: 51
Study 17074548 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 2019
Study 17074548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2019
Study 14715857 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 19
Study 14715857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 11440284 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg
Number of subjects: 818
Study 11440284 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg/HCTZ 12.5 mg
Number of subjects: 818
Study 9505800 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-feed soya formula with native phytic acid
Number of subjects: 0
Study 9505800 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray-dried soya formula with 110 mg ascorbic acid/l
Number of subjects: 0
Study 9505800 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk-based formula
Number of subjects: 0
Study 8117220 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 21
Study 8117220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 3076136 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 8
Study 3076136 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 8
Study 1441871 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine
Number of subjects: 18
Study 1441871 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine + Ornipressin
Number of subjects: 18
Study 1441871 — intervention group
Group type: COMPARATOR
Intervention: Prilocaine
Number of subjects: 18
Study 834800 — intervention group
Group type: EXPERIMENTAL
Intervention: 71 dB clicks presented in stimulus sequences consisting of a single click and a pair of clicks
Number of subjects: 12
Study 834800 — intervention group
Group type: EXPERIMENTAL
Intervention: Similar sequences of clicks with soft single clicks and loud pairs of clicks
Number of subjects: 12
Study 30928681 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Body Image (HBI) intervention
Number of subjects: 2446
Study 30928681 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2446
Study 28183318 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-modal early oral nutrition (EON)
Number of subjects: 107
Study 28183318 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 107
Study 26485460 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Hemodynamic Management (IHM)
Number of subjects: 167
Study 26485460 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 167
Study 23807067 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare delivery preferences
Number of subjects: 3611
Study 23807067 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare visits
Number of subjects: 3611
Study 23807067 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare delivery concerns
Number of subjects: 3611
Study 23807067 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-located gynecology with general healthcare
Number of subjects: 3611
Study 23807067 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration and coordination of care
Number of subjects: 3611
Study 21813428 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative exposure therapy (n = 29)
Number of subjects: 85
Study 21813428 — intervention group
Group type: COMPARATOR
Intervention: Academic catch-up program with elements of supportive counseling (n = 28)
Number of subjects: 85
Study 21813428 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (n = 28)
Number of subjects: 85
Study 20139566 — intervention group
Group type: EXPERIMENTAL
Intervention: Three‐step etch‐and‐rinse (Adper Scotchbond Multi‐Purpose, 3M ESPE‐SBMP)
Number of subjects: 24
Study 20139566 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐step etch‐and‐rinse (Adper Single Bond 2, 3 M ESPE‐SB)
Number of subjects: 24
Study 20139566 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐step self‐etch (AdheSE, Ivoclar/Vivadent‐AD)
Number of subjects: 24
Study 20139566 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐etch 1 step (Adper Prompt L‐Pop, 3M ESPE‐LP)
Number of subjects: 24
Study 16912024 — intervention group
Group type: EXPERIMENTAL
Intervention: delapril 30 mg twice daily
Number of subjects: 303
Study 16912024 — intervention group
Group type: EXPERIMENTAL
Intervention: delapril 15 mg twice daily
Number of subjects: 303
Study 16912024 — intervention group
Group type: EXPERIMENTAL
Intervention: delapril 30 mg once daily
Number of subjects: 303
Study 16912024 — intervention group
Group type: EXPERIMENTAL
Intervention: delapril 7.5 mg twice daily
Number of subjects: 303
Study 16912024 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 303
Study 16912024 — intervention group
Group type: EXPERIMENTAL
Intervention: delapril
Number of subjects: 303
Study 14685864 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced household tasks (sweeping, window cleaning, vacuuming, mowing)
Number of subjects: 36
Study 14685864 — intervention group
Group type: COMPARATOR
Intervention: Home environment
Number of subjects: 36
Study 14685864 — intervention group
Group type: COMPARATOR
Intervention: Laboratory environment
Number of subjects: 36
Study 14685864 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy expenditure prediction
Number of subjects: 36
Study 14685864 — intervention group
Group type: EXPERIMENTAL
Intervention: Household chores
Number of subjects: 36
Study 14685864 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced energy expenditure
Number of subjects: 36
Study 11246578 — intervention group
Group type: EXPERIMENTAL
Intervention: High work-related stress (highest stress quintile)
Number of subjects: 467
Study 11246578 — intervention group
Group type: COMPARATOR
Intervention: Low work-related stress (lowest stress quintile)
Number of subjects: 467
Study 11246578 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-related stress in women
Number of subjects: 467
Study 9885118 — intervention group
Group type: EXPERIMENTAL
Intervention: Early extubation after cardiac surgery
Number of subjects: 266
Study 7993326 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 5, 10, and 20% carbon dioxide (CO2)
Number of subjects: 49
Study 7993326 — intervention group
Group type: COMPARATOR
Intervention: Inhalation of room air
Number of subjects: 49
Study 2701745 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (BUS, 10 mg)
Number of subjects: 12
Study 2701745 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (DZP, 10 mg)
Number of subjects: 12
Study 30715255 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopic ablation
Number of subjects: 124
Study 30715255 — intervention group
Group type: COMPARATOR
Intervention: Catheter ablation
Number of subjects: 124
Study 28847326 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrub 1 (scrubs with a complex element compound with a silver-alloy embedded in its fibers)
Number of subjects: 40
Study 28847326 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrub 2 (scrubs impregnated with an organosilane-based quaternary ammonium and a hydrophobic fluoroacrylate copolymer emulsion)
Number of subjects: 40
Study 28847326 — intervention group
Group type: COMPARATOR
Intervention: Control (standard cotton-polyester surgical scrubs)
Number of subjects: 40
Study 26096109 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ozone therapy
Number of subjects: 40
Study 23500091 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg IM every 4 weeks
Number of subjects: 35
Study 21396763 — intervention group
Group type: EXPERIMENTAL
Intervention: Suctioning via the endotracheal tube during laryngoscopy
Number of subjects: 41
Study 21396763 — intervention group
Group type: COMPARATOR
Intervention: Standard intubation strategy with suctioning using a separate catheter
Number of subjects: 41
Study 21396763 — intervention group
Group type: EXPERIMENTAL
Intervention: Suctioning via the endotracheal tube
Number of subjects: 41
Study 21396763 — intervention group
Group type: COMPARATOR
Intervention: Standard intubation strategy
Number of subjects: 41
Study 18438122 — intervention group
Group type: EXPERIMENTAL
Intervention: Imprint cytology for intraoperative diagnosis of sentinel node metastases
Number of subjects: 631
Study 18438122 — intervention group
Group type: EXPERIMENTAL
Intervention: Imprint cytology positive results
Number of subjects: 631
Study 18438122 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for second axillary operation
Number of subjects: 631
Study 16792615 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Trach
Number of subjects: 90
Study 16792615 — intervention group
Group type: EXPERIMENTAL
Intervention: McCoy
Number of subjects: 90
Study 16792615 — intervention group
Group type: EXPERIMENTAL
Intervention: ILMA
Number of subjects: 90
Study 12615021 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk filling technique (G7 and G8)
Number of subjects: 10
Study 12615021 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental filling techniques (G1, G2, G3, G4, G5, G6)
Number of subjects: 10
Study 12615021 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-viscosity composite liner (Tetric Flow Chroma)
Number of subjects: 10
Study 12615021 — intervention group
Group type: COMPARATOR
Intervention: Control group (flat dentin surfaces, G9 and G10)
Number of subjects: 10
Study 11550733 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic-relaxation training
Number of subjects: 33
Study 11550733 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hypnotic-relaxation training)
Number of subjects: 33
Study 9593133 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg of sulbactam with 2,000 mg of ampicillin by intravenous bolus injection (3 min), repeated after 2 hours.
Number of subjects: 16
Study 9593133 — intervention group
Group type: COMPARATOR
Intervention: 1,000 mg of sulbactam with 2,000 mg of ampicillin by bolus injection (3 min) followed by a continuous infusion of the same dose over 4 hours.
Number of subjects: 16
Study 8112244 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine-CR (CBZ-CR) 20 mg/kg as a single loading dose
Number of subjects: 42
Study 8112244 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) 20 mg/kg (two-thirds at 0 h and one-third at 2 h)
Number of subjects: 42
Study 8112244 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine-CR and Phenytoin
Number of subjects: 42
Study 3293400 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 3234
Study 3293400 — intervention group
Group type: COMPARATOR
Intervention: Thiazide diuretic
Number of subjects: 3234
Study 30397934 — intervention group
Group type: EXPERIMENTAL
Intervention: TeenPower mHealth programme (Group A: with structured school-based intervention; Group B: only mHealth programme)
Number of subjects: 0
Study 30397934 — intervention group
Group type: COMPARATOR
Intervention: Structured school-based intervention programme (Control group)
Number of subjects: 0
Study 27718000 — intervention group
Group type: EXPERIMENTAL
Intervention: bosutinib with aprepitant (125 mg × 1)
Number of subjects: 19
Study 27718000 — intervention group
Group type: COMPARATOR
Intervention: bosutinib alone (100 mg × 5)
Number of subjects: 19
Study 26576497 — intervention group
Group type: EXPERIMENTAL
Intervention: Subpleural analgesia (SPA)
Number of subjects: 30
Study 26576497 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 30
Study 25380241 — intervention group
Group type: EXPERIMENTAL
Intervention: BV 1 treatment (1:10,000 concentration BVA plus physiotherapy)
Number of subjects: 60
Study 25380241 — intervention group
Group type: EXPERIMENTAL
Intervention: BV 2 treatment (1:30,000 concentration BVA plus physiotherapy)
Number of subjects: 60
Study 25380241 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (normal saline injection plus physiotherapy)
Number of subjects: 60
Study 22466026 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (20 minutes of daily postural and movement activities for 4 weeks)
Number of subjects: 22
Study 22466026 — intervention group
Group type: COMPARATOR
Intervention: Control group (social interaction for 4 weeks)
Number of subjects: 22
Study 22466026 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 22
Study 18583515 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic analysis of saturation and respiratory signal (automatic RDI [RDIa] and automatic desaturation index of 3% [DI3%a])
Number of subjects: 218
Study 18583515 — intervention group
Group type: COMPARATOR
Intervention: Visual respiratory disturbance index (RDI)
Number of subjects: 218
Study 17601465 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized education and structured telephone counseling follow-up
Number of subjects: 150
Study 17601465 — intervention group
Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 150
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive postremission chemotherapy
Number of subjects: 922
Study 15353542 — intervention group
Group type: COMPARATOR
Intervention: Less intensive postremission chemotherapy
Number of subjects: 922
Study 15353542 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 922
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous SCT
Number of subjects: 922
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic SCT
Number of subjects: 922
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard four-drug/4-week induction course
Number of subjects: 922
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-matched sibling transplant
Number of subjects: 922
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: Philadelphia chromosome-positive ALL
Number of subjects: 922
Study 15353542 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS-positive ALL
Number of subjects: 922
Study 11594640 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intensity of rehabilitation therapy input without change in content
Number of subjects: 56
Study 11594640 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy
Number of subjects: 56
Study 9657471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting Balloon angioplasty
Number of subjects: 64
Study 9657471 — intervention group
Group type: COMPARATOR
Intervention: Conventional balloon angioplasty
Number of subjects: 64
Study 10829905 — intervention group
Group type: EXPERIMENTAL
Intervention: FT‐AGA with asphyxia (n = 15)
Number of subjects: 72
Study 10829905 — intervention group
Group type: EXPERIMENTAL
Intervention: FT‐IUGR with asphyxia (n = 10)
Number of subjects: 72
Study 10829905 — intervention group
Group type: EXPERIMENTAL
Intervention: PT‐AGA with asphyxia (n = 10)
Number of subjects: 72
Study 10829905 — intervention group
Group type: COMPARATOR
Intervention: Bicarbonate-treated asphyxiated infants
Number of subjects: 72
Study 10829905 — intervention group
Group type: COMPARATOR
Intervention: Control infants (without asphyxia)
Number of subjects: 72
Study 2144208 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoladex 3.6 mg as a depot preparation combined with flutamide 250 mg tid
Number of subjects: 591
Study 2144208 — intervention group
Group type: COMPARATOR
Intervention: Orchiectomy
Number of subjects: 591
Study 364923 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 28
Study 30536932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led sleep programme (4 weekly 1-hr sessions)
Number of subjects: 52
Study 30536932 — intervention group
Group type: COMPARATOR
Intervention: Regular nursing home services
Number of subjects: 52
Study 30536932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led sleep programme
Number of subjects: 52
Study 27153860 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual power
Number of subjects: 270
Study 27153860 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved power
Number of subjects: 270
Study 27153860 — intervention group
Group type: EXPERIMENTAL
Intervention: Attempted power
Number of subjects: 270
Study 25928315 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored knowledge acquisition intervention
Number of subjects: 1159
Study 25928315 — intervention group
Group type: COMPARATOR
Intervention: Nontailored control
Number of subjects: 1159
Study 23601796 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic balanced solutions (crystalloid and hydroxyethyl starch; balanced group)
Number of subjects: 42
Study 23601796 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium chloride solutions (crystalloid and hydroxyethyl starch; saline group)
Number of subjects: 42
Study 21409399 — intervention group
Group type: EXPERIMENTAL
Intervention: copy‐typing (typing)
Number of subjects: 14
Study 21409399 — intervention group
Group type: EXPERIMENTAL
Intervention: typing at progressively faster speed (pacing)
Number of subjects: 14
Study 21409399 — intervention group
Group type: EXPERIMENTAL
Intervention: mental arithmetic plus fast typing (subtraction)
Number of subjects: 14
Study 21409399 — intervention group
Group type: COMPARATOR
Intervention: rest periods
Number of subjects: 14
Study 21409399 — intervention group
Group type: COMPARATOR
Intervention: baseline
Number of subjects: 14
Study 18620827 — intervention group
Group type: EXPERIMENTAL
Intervention: Endo-extralaryngeal needle carrier (EENC)
Number of subjects: 11
Study 18620827 — intervention group
Group type: COMPARATOR
Intervention: Non-EENC
Number of subjects: 11
Study 18236999 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (oral)
Number of subjects: 25
Study 18236999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 14692951 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 0
Study 14692951 — intervention group
Group type: COMPARATOR
Intervention: Conventional haemorrhoidectomy
Number of subjects: 0
Study 11375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium alone
Number of subjects: 0
Study 11375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus low doses of conjugated equine estrogen
Number of subjects: 0
Study 11375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus conventional doses of conjugated equine estrogen
Number of subjects: 0